CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 87 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2018. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,458,600 | $5,630,000 | 5.96% |
| Carmignac Gestion | 2,485,652 | $5,692,000 | 0.09% |
| XTX Topco Ltd | 50,947 | $117,000 | 0.05% |
| Golden State Equity Partners | 31,327 | $72,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 78,274 | $179,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $725,000 | 0.01% |
| Newman Dignan & Sheerar, Inc. | 27,023 | $62,000 | 0.01% |
| Curi Wealth Management, LLC | 25,000 | $57,000 | 0.01% |
| Northeast Financial Consultants Inc | 53,000 | $121,000 | 0.01% |
| Assenagon Asset Management S.A. | 913,789 | $2,093,000 | 0.01% |